Mesoblast

$9.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.58 (-5.74%) Today

+$0.01 (+0.15%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Mesoblast and other stocks, options, and ETFs commission-free!

About MESO

Mesoblast Limited American Depositary Shares, also called Mesoblast, is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. The listed name for MESO is Mesoblast Limited American Depositary Shares.

CEO

Silviu Itescu

Employees

102

Headquarters

Melbourne, Victoria (VIC)

Founded

2004

Market Cap

1.12B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

659.40K

High Today

$10.21

Low Today

$9.49

Open Price

$10.21

Volume

550.15K

52 Week High

$21.28

52 Week Low

$3.12

Analyst Ratings

50%

of 10 ratings

Buy

50%

Hold

30%

Sell

20%

MESO Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Mar 9, After Hours